dc.contributor.author
Yarur, Hector E.
dc.contributor.author
Vega Quiroga, Ignacio
dc.contributor.author
González, Marcela P.
dc.contributor.author
Noches, Verónica
dc.contributor.author
Thomases, Daniel R.
dc.contributor.author
Andrés, María E.
dc.contributor.author
Ciruela Alférez, Francisco
dc.contributor.author
Tseng, Kuei Y.
dc.contributor.author
Gysling, Katia
dc.date.issued
2020-11-10T12:08:57Z
dc.date.issued
2020-11-10T12:08:57Z
dc.date.issued
2020-02-01
dc.date.issued
2020-11-10T12:08:58Z
dc.identifier
https://hdl.handle.net/2445/171941
dc.description.abstract
Background: Basolateral amygdalar projections to the prefrontal cortex play a key role in modulating behavioral responses to stress stimuli. Among the different neuromodulators known to impact basolateral amygdalar-prefrontal cortex transmission, the corticotrophin releasing factor (CRF) is of particular interest because of its role in modulating anxiety and stress-associated behaviors. While CRF type 1 receptor (CRFR1) has been involved in prefrontal cortex functioning, the participation of CRF type 2 receptor (CRFR2) in basolateral amygdalar-prefrontal cortex synaptic transmission remains unclear. Methods: Immunofluorescence anatomical studies using rat prefrontal cortex synaptosomes devoid of postsynaptic elements were performed in rats with intra basolateral amygdalar injection of biotinylated dextran amine. In vivo microdialysis and local field potential recordings were used to measure glutamate extracellular levels and changes in long-term potentiation in prefrontal cortex induced by basolateral amygdalar stimulation in the absence or presence of CRF receptor antagonists. Results: We found evidence for the presynaptic expression of CRFR2 protein and mRNA in prefrontal cortex synaptic terminals originated from basolateral amygdalar. By means of microdialysis and electrophysiological recordings in combination with an intra-prefrontal cortex infusion of the CRFR2 antagonist antisauvagine-30, we were able to determine that CRFR2 is functionally positioned to limit the strength of basolateral amygdalar transmission to the prefrontal cortex through presynaptic inhibition of glutamate release. Conclusions: Our study shows for the first time to our knowledge that CRFR2 is expressed in basolateral amygdalar afferents projecting to the prefrontal cortex and exerts an inhibitory control of prefrontal cortex responses to basolateral amygdalar inputs. Thus, changes in CRFR2 signaling are likely to disrupt the functional connectivity of the basolateral amygdalar-prefrontal cortex pathway and associated behavioral responses.
dc.format
application/pdf
dc.format
application/pdf
dc.publisher
Oxford University Press
dc.relation
Reproducció del document publicat a: https://doi.org/10.1093/ijnp/pyz065
dc.relation
International Journal of Neuropsychopharmacology, 2020, vol. 23, num. 2, p. 108-116
dc.relation
https://doi.org/10.1093/ijnp/pyz065
dc.rights
cc-by-nc (c) Yarur, Hector E. et al., 2020
dc.rights
http://creativecommons.org/licenses/by-nc/3.0/es
dc.rights
info:eu-repo/semantics/openAccess
dc.source
Articles publicats en revistes (Patologia i Terapèutica Experimental)
dc.subject
Escorça cerebral
dc.subject
Cerebral cortex
dc.title
Inhibitory Control of Basolateral Amygdalar Transmission to the Prefrontal Cortex by Local Corticotrophin Type 2 Receptor
dc.type
info:eu-repo/semantics/article
dc.type
info:eu-repo/semantics/publishedVersion